Dr. Wing Leung, St Jude Children's Research Hospital - $25k

TMLTF specific interests are aligned with Dr. Leung’s U.S. patent for genetically modified human immune cells for cancer therapy; Protocol INFT2: HLA - Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less than 2 years old. TMLTF is eternally grateful to The St Jude Children’s Hospital, Dr. Leung, and his entire team (clinical support staff and ICU team), who tried desperately to save Mya, and who gifted us with an additional two years of life, having been sent home previously, on hospice.